An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.
Saved in:
| Title: | An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study. |
|---|---|
| Authors: | Wang YH; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Gurnari C; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy., Visconte V; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Durmaz A; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Guarnera L; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Lee WH; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Hsinchu City, Taiwan., Yao CY; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Jerez A; Haematology Department, Hospital Morales Meseguer, Murcia, Spain., Gurashi K; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Batta K; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Hou HA; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Patnaik MS; Mayo Clinic College of Medicine, Rochester, Minnesota, USA., Maciejewski J; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Wiseman DH; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Lin CC; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan., Tien HF; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan. |
| Source: | Cancer science [Cancer Sci] 2026 Apr 28. Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42046464 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+YH%22">Wang YH</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Gurnari+C%22">Gurnari C</searchLink>; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Visconte+V%22">Visconte V</searchLink>; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Durmaz+A%22">Durmaz A</searchLink>; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Guarnera+L%22">Guarnera L</searchLink>; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Lee+WH%22">Lee WH</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Hsinchu City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yao+CY%22">Yao CY</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Jerez+A%22">Jerez A</searchLink>; Haematology Department, Hospital Morales Meseguer, Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Gurashi+K%22">Gurashi K</searchLink>; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Batta+K%22">Batta K</searchLink>; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Hou+HA%22">Hou HA</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chou+WC%22">Chou WC</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Patnaik+MS%22">Patnaik MS</searchLink>; Mayo Clinic College of Medicine, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Maciejewski+J%22">Maciejewski J</searchLink>; Department of Translational Haematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Wiseman+DH%22">Wiseman DH</searchLink>; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tien+HF%22">Tien HF</searchLink>; Division of Haematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2026 Apr 28. <i>Date of Electronic Publication: </i>2026 Apr 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42046464 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cas.70405 Languages: – Code: eng Text: English Titles: – TitleFull: An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang YH – PersonEntity: Name: NameFull: Gurnari C – PersonEntity: Name: NameFull: Visconte V – PersonEntity: Name: NameFull: Durmaz A – PersonEntity: Name: NameFull: Guarnera L – PersonEntity: Name: NameFull: Lee WH – PersonEntity: Name: NameFull: Yao CY – PersonEntity: Name: NameFull: Jerez A – PersonEntity: Name: NameFull: Gurashi K – PersonEntity: Name: NameFull: Batta K – PersonEntity: Name: NameFull: Hou HA – PersonEntity: Name: NameFull: Chou WC – PersonEntity: Name: NameFull: Patnaik MS – PersonEntity: Name: NameFull: Maciejewski J – PersonEntity: Name: NameFull: Wiseman DH – PersonEntity: Name: NameFull: Lin CC – PersonEntity: Name: NameFull: Tien HF IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 04 Text: 2026 Apr 28 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1349-7006 Titles: – TitleFull: Cancer science Type: main |
| ResultId | 1 |